Total Payments
$20,177
2024 Payments
$2,679
Companies
23
Transactions
156
Medicare Patients
3,074
Medicare Billing
$675,076
Payment Breakdown by Category
Travel$8,209 (40.7%)
Food & Beverage$6,716 (33.3%)
Consulting$5,252 (26.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $8,209 | 23 | 40.7% |
| Food and Beverage | $6,716 | 129 | 33.3% |
| Consulting Fee | $5,252 | 4 | 26.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $15,690 | 86 | $0 (2024) |
| CVRx, Inc. | $2,233 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $709.35 | 19 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $202.28 | 5 | $0 (2018) |
| CathWorks, Inc. | $152.49 | 2 | $0 (2019) |
| ABIOMED | $137.14 | 2 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $128.88 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $121.62 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $119.53 | 2 | $0 (2024) |
| Amgen Inc. | $104.90 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,679 | 19 | CVRx, Inc. ($2,094) |
| 2023 | $260.03 | 2 | CVRx, Inc. ($138.41) |
| 2022 | $1,889 | 11 | Abbott Laboratories ($1,777) |
| 2021 | $323.92 | 13 | Abbott Laboratories ($219.10) |
| 2020 | $1,165 | 11 | Abbott Laboratories ($1,014) |
| 2019 | $4,017 | 28 | Abbott Laboratories ($3,532) |
| 2018 | $6,188 | 35 | Abbott Laboratories ($5,647) |
| 2017 | $3,655 | 37 | Abbott Laboratories ($3,317) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $725.95 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Heart Failure | ||||||
| 10/22/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $31.85 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/15/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.73 | General |
| 09/10/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $43.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $41.56 | General |
| Category: Cardiovascular | ||||||
| 07/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $532.94 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $131.54 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $103.76 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $59.95 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $276.06 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $203.05 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.03 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/10/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $128.88 | General |
| Category: Cardiovascular Device | ||||||
| 07/08/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Heart Failure | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.73 | General |
| 05/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $68.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $155.96 | General |
| Category: Heart Failure | ||||||
| 05/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $68.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $138.41 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/06/2023 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $121.62 | General |
| 11/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DIABETES | ||||||
| 11/10/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Heart Failure | ||||||
| 11/09/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $46.60 | General |
| Category: Heart Failure | ||||||
| 10/19/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $700.64 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 876 | 2,006 | $909,803 | $207,997 |
| 2022 | 10 | 820 | 1,705 | $723,293 | $176,535 |
| 2021 | 13 | 746 | 1,672 | $718,644 | $178,435 |
| 2020 | 12 | 632 | 1,260 | $441,256 | $112,109 |
Total Patients
3,074
Total Services
6,643
Medicare Billing
$675,076
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 57 | 388 | $371,316 | $73,457 | 19.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 297 | $108,405 | $31,793 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 178 | $64,792 | $19,350 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 74 | 136 | $66,504 | $17,086 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 95 | $46,455 | $14,972 | 32.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 105 | 115 | $67,133 | $14,923 | 22.2% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 43 | 314 | $68,452 | $10,981 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 88 | $32,032 | $7,078 | 22.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 50 | 59 | $14,632 | $3,687 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 23 | $16,192 | $3,567 | 22.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 213 | 228 | $18,924 | $2,899 | 15.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $10,455 | $2,899 | 27.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 12 | 12 | $12,984 | $2,816 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $6,094 | $1,668 | 27.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 17 | $2,213 | $498.99 | 22.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 12 | 17 | $1,309 | $209.27 | 16.0% |
| 76376 | 3d radiographic procedure | Office | 2023 | 12 | 13 | $1,911 | $112.06 | 5.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 41 | 231 | $216,678 | $44,410 | 20.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 349 | $124,942 | $32,645 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 84 | 142 | $67,450 | $18,095 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 165 | $58,245 | $17,829 | 30.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 123 | 134 | $74,178 | $17,687 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 105 | $49,875 | $17,673 | 35.4% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 39 | 205 | $43,255 | $7,174 | 16.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 36 | $24,840 | $6,478 | 26.1% |
About Dr. Jared Herr, MD
Dr. Jared Herr, MD is a Cardiovascular Disease healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1184959272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jared Herr, MD has received a total of $20,177 in payments from pharmaceutical and medical device companies, with $2,679 received in 2024. These payments were reported across 156 transactions from 23 companies. The most common payment nature is "Travel and Lodging" ($8,209).
As a Medicare-enrolled provider, Herr has provided services to 3,074 Medicare beneficiaries, totaling 6,643 services with total Medicare billing of $675,076. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location San Francisco, CA
- Active Since 10/07/2009
- Last Updated 05/29/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1184959272
Products in Payments
- CRT-Ds (Device) $4,202
- HeartMate 3 Left Ventricular Dev (Device) $3,393
- Circulatory Support (Device) $3,258
- Barostim Neo System (Device) $2,233
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,482
- HeartMate (Device) $1,183
- CardioMEMS HF System (Device) $1,164
- LifeVest (Device) $709.35
- HeartMate Touch (Device) $541.24
- Mitra Clip system (Device) $266.93
- HeartMate 3 Left Ventricular Assist Device (Device) $156.02
- FFRangio System (Device) $152.49
- Impella (Device) $137.14
- Optimizer (Device) $128.88
- ZORTRESS (Drug) $106.58
- ENTRESTO (Drug) $95.70
- Adempas (Drug) $91.79
- JARDIANCE (Drug) $84.37
- Corlanor (Drug) $73.79
- ZIO XT Patch (Device) $43.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Francisco
Dr. Philip Sager, Md, MD
Cardiovascular Disease — Payments: $851,687
Cardiovascular Disease $851,687
Dr. Melvin Scheinman, M.d, M.D
Cardiovascular Disease — Payments: $315,387
Cardiovascular Disease $315,387
Dr. Henry Hsia, Md, MD
Cardiovascular Disease — Payments: $296,299
Cardiovascular Disease $296,299
Edward Gerstenfeld, Md, MD
Cardiovascular Disease — Payments: $198,638
Cardiovascular Disease $198,638
Dr. Lloyd Klein, Md, MD
Cardiovascular Disease — Payments: $176,194
Cardiovascular Disease $176,194
Robert Gillespie, M.d, M.D
Cardiovascular Disease — Payments: $116,323
Cardiovascular Disease $116,323